Skip to content

A Randomized Controlled Trial on the Effectiveness of Gait Rehabilitation after Thoracic Myelopathy Surgery

A Randomized Controlled Trial on the Effectiveness of Gait Rehabilitation in the Acute Postoperative Phase of Compression Thoracic Myelopathy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs032250191
Enrollment
20
Registered
2025-06-27
Start date
2025-06-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients determined to require postoperative rehabilitation

Interventions

Sponsors

Murata Atushi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Patients who have been fully informed of the study and who have given written consent of their own free will after full understanding of the study 2)Patients undergoing surgery with a diagnosis of spondylotic thoracic myelopathy, ossification of the posterior longitudinal ligament, ossification of the yellow ligament, or extramedullary tumor of the spinal cord 3)Before surgery, patients must score 1 or 2 on the Japanese Orthopedic Association-Leg Motor Function (JOA-LE) of the Japanese Orthopedic Association Cervical Myelopathy Treatment Outcome Criteria. 4)Eligible age is between 35 and 75 years old 5)Gender-neutral 6)Patients who can be followed up in the hospital for 6 months after surgery

Exclusion criteria

Exclusion criteria: 1) History of myelopathy surgery 2) Patients with impaired consciousness 3) Patients with concomitant neurological diseases that may affect the evaluation of neurological symptoms, such as cerebral infarction 4)Patients with preoperative and postoperative lower extremity muscle strength scores totaling 42 or less on both sides or MMT 3 or less in one of the key muscles, consisting of muscles representing the 5 myelinated segments L2-S1 of the ASIA assessment criteria 5)Other patients judged unsuitable for the study by the investigator(s)

Design outcomes

Primary

MeasureTime frame
Change in 10 m maximum walking speed (m/sec) before and 14 days after surgery

Secondary

MeasureTime frame
1)10m maximum walking speed (m/sec) (crude point and amount of change) 2)Percentage of 0.1 m/sec improvement in 10 m maximum walking speed (m/sec) change 3)Change in 10m maximum walking speed (m/sec) by the number of times rehabilitation is performed 4)10m maximum walking speed (steps) (crude point and amount of change) 5)Change in 10m maximum walking speed (m/sec) relative to change in JOA score 6)Amount of change in Timed up and Go test (sec) 7)JOA-LE (crude point and amount of change) 8)2-minute walk (crude point and amount of change) 9)Frequency of adverse event

Contacts

Public ContactRyo Fukata

Chiba University Hospital

alice_cute_0312@chiba-u.jp+81-43-222-7171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026